Author = Elham Moases Ghaffary
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Fardin Nabizadeh; Elham Ramezannezhad; Kimia Kazemzadeh; Elham Khalili; Elham Moases Ghaffary; Omid Mirmosayyeb


Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mohammad Yazdan Panah; Saeed Vaheb; Yousef Mokary; Elham Moases Ghaffary; Alireza Afshari-Safavi; Aysa Shaygannejad; Narges Ebrahimi; Vahid Shaygannejad; Omid Mirmosayyeb


Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis

Volume 2, Issue 2, July 2023, Pages 97-105

10.61186/nl.2.2.97

Fardin Nabizadeh; Nazanin Rafiei; Seyedeh Maryam Vafaei; Mobin Azami; kimia rasouli; Elham Moases Ghaffary; Omid Mirmosayyeb


Optical Coherence Tomography (OCT) Measurements and Disability in Multiple Sclerosis (MS): Protocol of Systematic Review

Volume 2, Issue 1, April 2023, Pages 44-46

10.52547/nl.2.1.44

Omid Mirmosayyeb; Elham Moases Ghaffary